Keitaro Kanda

870 total citations
9 papers, 686 citations indexed

About

Keitaro Kanda is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Keitaro Kanda has authored 9 papers receiving a total of 686 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Immunology and 2 papers in Surgery. Recurrent topics in Keitaro Kanda's work include Chemokine receptors and signaling (2 papers), Pancreatic and Hepatic Oncology Research (1 paper) and Liver Disease and Transplantation (1 paper). Keitaro Kanda is often cited by papers focused on Chemokine receptors and signaling (2 papers), Pancreatic and Hepatic Oncology Research (1 paper) and Liver Disease and Transplantation (1 paper). Keitaro Kanda collaborates with scholars based in Japan, Greece and United States. Keitaro Kanda's co-authors include Hiroshi Seno, Yuki Nakanishi, Hideyuki Komekado, Yoshiharu Sakai, Kenji Kawada, Taro Ueo, Mayumi Kawada, Makoto M. Taketo, Tsutomu Chiba and Motoko Yanagita and has published in prestigious journals such as Nature Genetics, PLoS ONE and Gut.

In The Last Decade

Keitaro Kanda

9 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keitaro Kanda Japan 6 398 237 235 125 94 9 686
Taro Ueo Japan 7 332 0.8× 141 0.6× 281 1.2× 118 0.9× 91 1.0× 19 642
Xuefeng Hua China 9 317 0.8× 317 1.3× 195 0.8× 148 1.2× 50 0.5× 21 691
Isabelle Soubeyran France 14 362 0.9× 162 0.7× 369 1.6× 168 1.3× 76 0.8× 25 767
Irene Gómez Spain 9 358 0.9× 145 0.6× 338 1.4× 156 1.2× 55 0.6× 11 645
Gali Soria Israel 6 534 1.3× 381 1.6× 288 1.2× 119 1.0× 28 0.3× 7 845
M Buscemi Italy 9 327 0.8× 164 0.7× 260 1.1× 109 0.9× 41 0.4× 18 637
Kosei Nakajima Japan 14 165 0.4× 264 1.1× 297 1.3× 61 0.5× 63 0.7× 36 575
Ya Yuan China 8 285 0.7× 406 1.7× 307 1.3× 146 1.2× 44 0.5× 16 822
Erica Julianne Lay United States 5 241 0.6× 86 0.4× 306 1.3× 167 1.3× 132 1.4× 7 586
Beatriz Soldevilla Spain 15 389 1.0× 200 0.8× 523 2.2× 295 2.4× 52 0.6× 25 918

Countries citing papers authored by Keitaro Kanda

Since Specialization
Citations

This map shows the geographic impact of Keitaro Kanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keitaro Kanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keitaro Kanda more than expected).

Fields of papers citing papers by Keitaro Kanda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keitaro Kanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keitaro Kanda. The network helps show where Keitaro Kanda may publish in the future.

Co-authorship network of co-authors of Keitaro Kanda

This figure shows the co-authorship network connecting the top 25 collaborators of Keitaro Kanda. A scholar is included among the top collaborators of Keitaro Kanda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keitaro Kanda. Keitaro Kanda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Fukuda, Akihisa, Satoshi Ogawa, Norihiro Goto, et al.. (2018). Nardilysin inhibits pancreatitis and suppresses pancreatic ductal adenocarcinoma initiation in mice. Gut. 68(5). 882–892. 5 indexed citations
2.
Seno, Hiroshi, Eiichiro Nishi, Y Matsumoto, et al.. (2014). Deletion of Nardilysin Prevents the Development of Steatohepatitis and Liver Fibrotic Changes. PLoS ONE. 9(5). e98017–e98017. 12 indexed citations
3.
Seno, Hiroshi, Yuki Nakanishi, Keitaro Kanda, et al.. (2013). Inhibitory role of Gas6 in intestinal tumorigenesis. Carcinogenesis. 34(7). 1567–1574. 36 indexed citations
4.
Kawada, Kenji, Masayoshi Iwamoto, Koya Hida, et al.. (2012). The role of CXCR3 and CXCR4 in colorectal cancer metastasis. International Journal of Cancer. 132(2). 276–287. 115 indexed citations
5.
Kanda, Keitaro, Hideyuki Komekado, Tateo Sawabu, et al.. (2012). Nardilysin and ADAM proteases promote gastric cancer cell growth by activating intrinsic cytokine signalling via enhanced ectodomain shedding of TNF‐α. EMBO Molecular Medicine. 4(5). 396–411. 33 indexed citations
6.
Nakanishi, Yuki, Hiroshi Seno, Ayumi Fukuoka, et al.. (2012). Dclk1 distinguishes between tumor and normal stem cells in the intestine. Nature Genetics. 45(1). 98–103. 318 indexed citations
7.
Nakanishi, Yuki, Hiroshi Seno, Keitaro Kanda, et al.. (2011). COX-2 inhibition alters the phenotype of tumor-associated macrophages from M2 to M1 in ApcMin/+ mouse polyps. Carcinogenesis. 32(9). 1333–1339. 163 indexed citations
8.
Nakanishi, Yuki, Keitaro Kanda, Reiko Akitake, et al.. (2010). Metastatic gastrointestinal stromal tumors mimicking gastrointestinal polyposis. Endoscopy. 42(S 02). E37–E38. 1 indexed citations
9.
Kanda, Keitaro, Takahisa Kayahara, Hiroshi Seno, Yukitaka Yamashita, & Tsutomu Chiba. (2008). Conversion from Latent to Symptomatic Sheehan's Syndrome by Pegylated Interferon Therapy for Chronic Hepatitis C. Internal Medicine. 47(10). 939–941. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026